A Phase 2A Clinical Trial of EPI-743 in Patients with Parkinson’s Disease

Kelly L. Sullivan

A Phase 2A Clinical Trial of EPI-743 in Patients with Parkinson’s Disease

Kelly L. Sullivan

Biostatistics, Epidemiology & Environmental Health Sciences

Research output: Other contribution › Other

Original language	American English
State	Published - 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Disciplines

Epidemiology
Public Health

Cite this

@misc{7eeea2d9ff2d49a6b12051bd465654a1,

title = "A Phase 2A Clinical Trial of EPI-743 in Patients with Parkinson{\textquoteright}s Disease",

author = "Sullivan, \{Kelly L.\}",

note = "Kelly L. Sullivan (Project Manager). {"}A Phase 2A Clinical Trial of EPI-743 in Patients with Parkinson{\textquoteright}s Disease,{"} Edison Pharmaceuticals, Inc. (Investigator Initiated). (2012-present).",

year = "2012",

language = "American English",

type = "Other",

}